Free Trial
NASDAQ:PHVS

Pharvaris (PHVS) Stock Price, News & Analysis

Pharvaris logo
$18.76 +0.94 (+5.27%)
As of 07/3/2025 02:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Pharvaris Stock (NASDAQ:PHVS)

Key Stats

Today's Range
$17.40
$18.80
50-Day Range
$15.46
$18.76
52-Week Range
$11.51
$25.50
Volume
29,451 shs
Average Volume
71,304 shs
Market Capitalization
$980.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$36.20
Consensus Rating
Buy

Company Overview

Pharvaris Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
31st Percentile Overall Score

PHVS MarketRank™: 

Pharvaris scored higher than 31% of companies evaluated by MarketBeat, and ranked 759th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Pharvaris has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Pharvaris has only been the subject of 3 research reports in the past 90 days.

  • Read more about Pharvaris' stock forecast and price target.
  • Earnings Growth

    Earnings for Pharvaris are expected to decrease in the coming year, from ($2.71) to ($3.06) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Pharvaris is -6.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Pharvaris is -6.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Pharvaris has a P/B Ratio of 3.39. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Pharvaris' valuation and earnings.
  • Percentage of Shares Shorted

    4.50% of the float of Pharvaris has been sold short.
  • Short Interest Ratio / Days to Cover

    Pharvaris has a short interest ratio ("days to cover") of 11.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Pharvaris has recently increased by 8.70%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Pharvaris does not currently pay a dividend.

  • Dividend Growth

    Pharvaris does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.50% of the float of Pharvaris has been sold short.
  • Short Interest Ratio / Days to Cover

    Pharvaris has a short interest ratio ("days to cover") of 11.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Pharvaris has recently increased by 8.70%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Pharvaris has a news sentiment score of 1.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Pharvaris this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Pharvaris insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    11.84% of the stock of Pharvaris is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Pharvaris' insider trading history.
Receive PHVS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharvaris and its competitors with MarketBeat's FREE daily newsletter.

PHVS Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
See More Headlines

PHVS Stock Analysis - Frequently Asked Questions

Pharvaris' stock was trading at $19.17 on January 1st, 2025. Since then, PHVS shares have decreased by 2.1% and is now trading at $18.76.

Pharvaris N.V. (NASDAQ:PHVS) posted its quarterly earnings results on Tuesday, May, 13th. The company reported ($0.89) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.80) by $0.09.

Pharvaris (PHVS) raised $126 million in an initial public offering (IPO) on Friday, February 5th 2021. The company issued 7,000,000 shares at a price of $17.00-$19.00 per share. Morgan Stanley, BofA Securities and SVB Leerink acted as the underwriters for the IPO and Oppenheimer & Co. and Kempen & Co. were co-managers.

Shares of PHVS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pharvaris investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), e.l.f. Beauty (ELF), Jabil (JBL), Disc Medicine (IRON) and Adobe (ADBE).

Company Calendar

Last Earnings
5/13/2025
Today
7/06/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PHVS
Fax
N/A
Employees
30
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$36.20
High Stock Price Target
$55.00
Low Stock Price Target
$25.00
Potential Upside/Downside
+93.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$145.24 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$5.54 per share
Price / Book
3.39

Miscellaneous

Free Float
46,099,000
Market Cap
$980.96 million
Optionable
Not Optionable
Beta
-2.82
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:PHVS) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners